GO:0003824 |
F |
catalytic activity |
GO:0004957 |
F |
prostaglandin E receptor activity |
GO:0005737 |
C |
cytoplasm |
GO:0006629 |
P |
lipid metabolic process |
GO:0006631 |
P |
fatty acid metabolic process |
GO:0006693 |
P |
prostaglandin metabolic process |
GO:0007179 |
P |
transforming growth factor beta receptor signaling pathway |
GO:0007565 |
P |
female pregnancy |
GO:0007567 |
P |
parturition |
GO:0008152 |
P |
metabolic process |
GO:0016404 |
F |
15-hydroxyprostaglandin dehydrogenase (NAD+) activity |
GO:0016491 |
F |
oxidoreductase activity |
GO:0030728 |
P |
ovulation |
GO:0045786 |
P |
negative regulation of cell cycle |
GO:0051287 |
F |
NAD binding |
GO:0055114 |
P |
obsolete oxidation-reduction process |
GO:0070403 |
F |
NAD+ binding |
GO:0070493 |
P |
thrombin-activated receptor signaling pathway |
GO:0097070 |
P |
ductus arteriosus closure |